New Report Shows 97 Medicines And Vaccines Currently In Development For HIV/AIDS

America’s pharmaceutical research and biotechnology companies are testing 97 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 marks the 21st anniversary of “World AIDS Day” a global awareness campaign that originated at the 1988 World Summit of Ministers of Health on Programmes for AIDS Prevention.

Source: New Report Shows 97 Medicines And Vaccines Currently In Development For HIV/AIDS

What Are Cold Sores? What Causes Cold Sores?

Cold sores (a cold sore), also known as fever blisters, are small sores, or blister-like lesions on the face or inside the mouth. They usually cause pain, a burning sensation, or itching before they burst and crust over. Most commonly, cold sores appear on the lips, chin, cheeks, inside the nostrils, and less frequently on the gums or the palate (roof of the mouth).

Source: What Are Cold Sores? What Causes Cold Sores?

Some Patients Diagnosed With HIV Experience Improved Outlook On Life

A new study from researchers at the University of Cincinnati (UC) and the Cincinnati Department of Veterans Affairs Medical Center reaffirms that some patients with HIV experience an improved quality of life following their diagnosis. These findings are being published in the November issue of the journal AIDS Patient Care and STDs.

Source: Some Patients Diagnosed With HIV Experience Improved Outlook On Life

Long-Term Testicular Cancer Survivors At High Risk For Neurological Side Effects

Long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy had more severe side effects, including neurological side effects and Raynaud-like phenomena, than men who were not treated with chemotherapy, according to a new study published online November 25 in the Journal of the National Cancer Institute. Marianne Brydøy, M.D.

Source: Long-Term Testicular Cancer Survivors At High Risk For Neurological Side Effects

HIV/AIDS Treatment Specific To Each Patient Moves Closer To Reality

An innovative treatment for HIV patients developed by McGill University Health Centre researchers has passed its first clinical trial with flying colours. The new approach is an immunotherapy customized for each individual patient, and was developed by Dr. J-P. Routy from the Research Institute of the MUHC in collaboration with Dr. R. Sékaly from the Université de Montréal.

Source: HIV/AIDS Treatment Specific To Each Patient Moves Closer To Reality

« Previous Page — Next Page »